Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Qu XM, Chen Y, Zaric GS, Senan S, et al. Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of the SABR-COMET Randomized Trial. Int J Radiat Oncol Biol Phys 2021;109:1176-1184.
PMID: 33309977


Privacy Policy